Skip to content
healthcare.dev

Mesalamine

NDC 70771-1625, Mesalamine, capsule, extended release, from Zydus Lifesciences Limited.

Product NDC
70771-1625
Status
Listed
Labeler
Zydus Lifesciences Limited
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208954
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1625 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MESALAMINE.375 g/1

Pharmacologic classes

Aminosalicylate [EPC]; Aminosalicylic Acids [CS]

Package NDCNDC-11Package
70771-1625-770771162507120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70771-1625-7)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/04073681-a834-4f45-91c5-224b608b30e6

Use it

Look up 70771-1625 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1625 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70771-1625. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.